Update shared on 31 Oct 2025
Fair value Decreased 2.49%Analysts have revised their price target for Sasol downward from R134.11 to R130.78, citing slightly increased discount rates even though revenue growth and profit margin forecasts have improved.
What's in the News
- Sasol International Chemicals has launched and commercialized LIVINEX IO 7, a bio-circular, palm and deforestation-free surfactant made from insect oils (Key Developments).
- LIVINEX IO 7 is the first nonionic surfactant of its kind for the fabric, home care, industrial and institutional cleaning markets (Key Developments).
- The surfactant uses oil from black soldier fly larvae. This process transforms organic waste into valuable chemical feedstock, reducing reliance on traditional oleochemistry and avoiding land use changes (Key Developments).
- LIVINEX IO 7 is produced with mature technology and existing processes due to the chemical similarity between insect oil and vegetable oil, which eliminates competition with food crops (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has declined modestly from ZAR134.11 to ZAR130.78.
- Discount Rate has risen slightly from 22.78% to 24.01%.
- Revenue Growth expectations have increased from 4.00% to 4.42%.
- Net Profit Margin forecast has improved from 8.14% to 8.38%.
- Future P/E ratio has decreased slightly from 7.08x to 7.01x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.